The Polycystic Ovary Syndrome (PCOS) includes three phenotypic compartments
, not always fully associated, consisting in hyperandrogenism, anovulation
and metabolic syndrome, secondary to insulin resistance. The pathophysiolog
ical grounds lie upon two main components, i.e.: the theca-interstitial cel
l (TIC) and the granulosa cell (GC) dysregulations, the former accounting f
or hyperandrogenism and the latter for anovulation, and both of them being
under the influence of hyperinsulinism. The former mainly results from an e
nzymatic overactivity, yielding an exaggerated output of androgens by the T
IC, but the type(s) of enzymes as well as the genetic or adaptative nature
of its (their) dysregulation are still controversial. The main consequence
of the CG dysregulation is the follicular arrest just before the time of do
minance. This might result from an intrinsic abnormality in CG, involving t
he IGFs and/or the Inhibin/Activin/Follistatin systems. Alternatively, the
CTI might have deleterious effects on GC, mainly via the intra-ovarian hype
randrogenism. The latter should not be regarded any more as an atretogenic
phenomenon. It is closely related to the two main morphological features of
PCOS, i.e.: the stromal hyperplasia and the excessive follicular number.